Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood pressure cuff trick may boost hand function in paralysis

NCT ID NCT03851302

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small study tested whether briefly restricting blood flow to one arm (called remote ischemic conditioning, or RIC) could improve hand function in people with spinal cord injury or ALS. Participants did hand exercises while receiving either active RIC or a sham version. The goal was to see if RIC could boost nerve signals and reduce inflammation. The study included 21 people and measured changes in muscle responses and blood markers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
remote ischemic conditioning (brief blood-flow restriction using a blood pressure cuff)
What this could lead to
If this approach works, it could point toward a simple, low-cost way to boost hand function during rehabilitation for people with spinal cord injury or ALS.
What could go wrong
This is a very small, early-stage study with only 21 participants. The results may not apply to everyone, and the effects might be too small to make a real difference in daily life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

21 people

The number who actually took part.

Started

Oct 2019

Finished

Oct 2022

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Able-bodied participants 1. Age between 18 and 75 years; 2. No known central or peripheral neurological disease or injury. SCI participants Inclusion Criteria: 1. Age between 18 and 75 years; 2. Chronic (more than 12 months since injury) motor-incomplete SCI between neurological levels C2-C8 3. Detectable F-wave responses of the left or right abductor pollicis brevis (APB) to median nerve stimulation; 4. Detectable motor evoked potentials in left or right APB muscles to transcranial magnetic stimulation; 5. Able to perform thumb-middle finger opposition pinch task with detectable APB EMG muscle activity. ALS participants 1. Age between 21 and 75 years; 2. Diagnosis of probable or definite ALS. 3. Incomplete weakness of left or right wrist or hand muscles: score of 2, 3, or 4 (out of 5) on manual muscle testing of finger extension, finger flexion, or finger abduction. 4. Detectable motor evoked potentials in left or right APB muscles to transcranial magnetic stimulation; 5. Able to perform thumb-middle finger opposition pinch task with detectable APB electromyography (EMG) muscle activity. Exclusion Criteria: 1. Multiple spinal cord lesions; 2. History of seizures; 3. Use of medications that significantly lower seizure threshold, such as amphetamines and bupropion; 4. History of implanted brain/spine/nerve stimulators, aneurysm clips, or cardiac pacemaker/defibrillator; 5. Any extremity soft tissue, orthopedic, or vascular condition or injury that may contraindicate remote limb ischemic conditioning (RLIC) (uncontrolled hypertension, peripheral vascular disease, hematological disease, severe hepatic or renal dysfunction); 6. Any other contraindication to undergoing magnetic resonance imaging (except for claustrophobia); 7. Clinically significant infection of any kind (urinary tract, pulmonary, skin or other) 8. Significant coronary artery or cardiac conduction disease; 9. Open skin lesions over the neck, shoulders, or arms; 10. Pregnancy 11. Unsuitable for study participation as determined by study physician. In addition, a medical record review will be conducted to identify any other medical concerns that might increase the risks associated with participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Amyotrophic lateral sclerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • James J. Peters VA Medical Center

    The Bronx, New York, 10468, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.